Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Lara

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Acta Psiquiatrica Y Psicologica De America Latina|September 1, 1984
[Combined modality therapeutic program for the control of smoking]M A Lara Cantú, G Oñate Rivadeneyra, M Balzaretti González, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|December 7, 2007
[Bevacizumab-induced serious heart failure in a patient treated with anthracyclines]S Fraile Gil, F J Hidalgo Correas, M A Lara Alvarez, et al.
Salud Publica De Mexico|November 1, 1996
[Epidemiologic aspects of the aged at the Mexican Institute of Social Security]M A Lara-Rodríguez, M G Benítez-Martínez, I H Fernández-Gárate, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 23, 2010
[Dabigatran in the treatment of a morbidly obese patient with recurring venous thrombosis]J L Callejas Rubio, M A Lara Jiménez, M A Fernández Pugnaire, et al.
Lupus|March 29, 2008
Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjogren's syndromeD Sánchez-Cano, J L Callejas-Rubio, M A Lara-Jiménez, et al.
Dermatologic Therapy|August 1, 2018
Omalizumab for the treatment of chronic spontaneous urticaria in daily clinical practice in South SpainR Ruiz-Villaverde, J J Pereyra-Rodriguez, C Hernández-Montoya, et al.
Medicina Intensiva|May 30, 2006
[Myocardial necrosis and cardiogenic shock with normal coronaries: cardiotoxicity due to 5-FU or catecholamine cardiomyopathy]J M Rodríguez Roldán, M A Lara Alvarez, J López Martínez, et al.
Vox Sanguinis|January 1, 1996
Seroprevalence of HTLV-I/II in different groups at risk in northeast MexicoP Zapata-Benavides, M A Lara-Rodríguez, J M Alcocer-González, et al.
Journal of Investigational Allergology & Clinical Immunology|October 5, 2023
Subcutaneous C1 Inhibitor for Long-term Prophylaxis of Hereditary Angioedema: A Real-life ExperienceK Baynova, S Cimbollek, J Quiralte, et al.
Brazilian Journal of Biology = Revista Brasleira De Biologia|April 24, 2024
Biological and chemical characterization in relation to the yield of radish (Raphanus sativus L.) nourished with humus from plant residuesD D Cruz Nieto, N E Muguruza Crispin, C M Caira Mamani, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Acta Psiquiatrica Y Psicologica De America Latina|September 1, 1984
[Combined modality therapeutic program for the control of smoking]M A Lara Cantú, G Oñate Rivadeneyra, M Balzaretti González, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|December 7, 2007
[Bevacizumab-induced serious heart failure in a patient treated with anthracyclines]S Fraile Gil, F J Hidalgo Correas, M A Lara Alvarez, et al.
Salud Publica De Mexico|November 1, 1996
[Epidemiologic aspects of the aged at the Mexican Institute of Social Security]M A Lara-Rodríguez, M G Benítez-Martínez, I H Fernández-Gárate, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 23, 2010
[Dabigatran in the treatment of a morbidly obese patient with recurring venous thrombosis]J L Callejas Rubio, M A Lara Jiménez, M A Fernández Pugnaire, et al.
Lupus|March 29, 2008
Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjogren's syndromeD Sánchez-Cano, J L Callejas-Rubio, M A Lara-Jiménez, et al.
Dermatologic Therapy|August 1, 2018
Omalizumab for the treatment of chronic spontaneous urticaria in daily clinical practice in South SpainR Ruiz-Villaverde, J J Pereyra-Rodriguez, C Hernández-Montoya, et al.
Medicina Intensiva|May 30, 2006
[Myocardial necrosis and cardiogenic shock with normal coronaries: cardiotoxicity due to 5-FU or catecholamine cardiomyopathy]J M Rodríguez Roldán, M A Lara Alvarez, J López Martínez, et al.
Vox Sanguinis|January 1, 1996
Seroprevalence of HTLV-I/II in different groups at risk in northeast MexicoP Zapata-Benavides, M A Lara-Rodríguez, J M Alcocer-González, et al.
Journal of Investigational Allergology & Clinical Immunology|October 5, 2023
Subcutaneous C1 Inhibitor for Long-term Prophylaxis of Hereditary Angioedema: A Real-life ExperienceK Baynova, S Cimbollek, J Quiralte, et al.
Brazilian Journal of Biology = Revista Brasleira De Biologia|April 24, 2024
Biological and chemical characterization in relation to the yield of radish (Raphanus sativus L.) nourished with humus from plant residuesD D Cruz Nieto, N E Muguruza Crispin, C M Caira Mamani, et al.
Pageof 2